According to Bliss GVS Pharma's latest financial reports the company has a price-to-book ratio of 1.22.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.35 | 61.29% |
2022-12-31 | 0.8388 | -31.42% |
2021-12-31 | 1.22 | -54.5% |
2020-12-31 | 2.69 | 24.95% |
2019-12-31 | 2.15 | -25.27% |
2018-12-31 | 2.88 | -18.99% |
2017-12-31 | 3.55 | 15.76% |
2016-12-31 | 3.07 | |
2013-12-31 | 1.39 | 64.83% |
2012-12-31 | 0.8404 |